Related Experiment Video
Updated: Apr 20, 2026
Tissue-specific miRNA Expression Profiling in Mouse Heart Sections Using In Situ Hybridization
Published on: September 15, 2018
Differential expression of microRNAs in ischemic heart disease
Minwoo A Song1, Alexandra N Paradis1, Maresha S Gay1
1Center for Perinatal Biology, Division of Pharmacology, Department of Basic Sciences, Loma Linda University School of Medicine, Loma Linda, CA 92350, USA.
Abstract:
Recent studies provide evidence that ischemic preconditioning (IP) and ischemia/reperfusion (IR) injury lead to altered expression of microRNAs (miRNAs) that affect the survival and recovery of cardiomyocytes. These endogenous ∼22-nucleotide noncoding RNAs negatively regulate gene expression via degradation and translational inhibition of their target mRNAs. miRNAs are involved in differentiation, proliferation, electrical conduction, angiogenesis and apoptosis. These pathways can lead to physiological and pathological adaptations. This review intends to explore several facets of miRNA expression and the underlying mechanisms involved in IR injury, as well as IP as a cardioprotective strategy. In addition, we will investigate miRNA interaction with the renin-angiotensin system and the potential use of miRNAs in developing sensitive biomarkers for cardiovascular disease.
Insights
MicroRNAs (miRNAs) are key regulators in heart cell survival and recovery following ischemia/reperfusion (IR) injury. This review explores miRNA roles in IR injury, cardioprotection, and cardiovascular disease biomarkers.
Area of Science:
- Cardiovascular Biology
- Molecular Biology
- Biochemistry
Background:
- Ischemic preconditioning (IP) and ischemia/reperfusion (IR) injury alter microRNA (miRNA) expression in cardiomyocytes.
- miRNAs are small noncoding RNAs regulating gene expression post-transcriptionally.
- These regulatory roles impact cardiomyocyte survival, proliferation, differentiation, and apoptosis.
Purpose of the Study:
- To review miRNA expression and mechanisms in IR injury.
- To explore the cardioprotective strategy of IP concerning miRNAs.
- To investigate miRNA interactions with the renin-angiotensin system and their potential as cardiovascular disease biomarkers.
Main Methods:
- Literature review of studies on miRNA expression in cardiac IR and IP.
- Analysis of miRNA regulatory mechanisms.
- Exploration of miRNA roles in physiological and pathological cardiac adaptations.
- Investigation of miRNA involvement in the renin-angiotensin system.
Main Results:
- Altered miRNA expression is a hallmark of cardiac IR injury and IP.
- miRNAs significantly influence key cellular processes critical for cardiac health.
- Specific miRNAs may serve as biomarkers for cardiovascular disease detection.
Conclusions:
- miRNAs are crucial in the cardiac response to IR injury and IP.
- Understanding miRNA regulation offers therapeutic targets for cardioprotection.
- miRNAs hold promise for developing novel cardiovascular disease biomarkers.
Related Concept Videos
01:22MicroRNAs
01:22MicroRNAs
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...